Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...

Sanofi is to buy Principia Biopharma for up to $3.68 billion, adding a potential multiple sclerosis drug to its pipeline. The French pharma said it will pay $100 per share in cash for San ...

Former Missouri Tigers quarterback Maty Mauk will take over as the head football coach at Principia High School this fall.

Former Missouri football quarterback Maty Mauk is now a high school head coach, taking over at Principia High in Town and ...

Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial ...

Maty Mauk will become a head football coach for the first time. The former Missouri quarterback was named the head coach of ...

WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a ...

FDA moves to block biopharma employees from serving on advisory committees By Gabrielle Masson Apr 18, 2025 11:10am FDA advisory committee Big Pharma Martin Makary ...

The sector saw an upturn in 2024, with 50 completed IPOs raising $8.52 billion, from $5.06 billion raised in 2023 and marking the highest total IPO value raised since 2021. This rebound, driven by US ...

Can-Fite BioPharma's Namodenoson gains FDA approval for compassionate use in pancreatic cancer; Phase IIa trial underway in Israel. Can-Fite BioPharma Ltd. announced that major U.S. medical ...